Generic legislation of new psychoactive drugs

Controlling new drugs under marketing regulations

(2012) Brendan Hughes et al.   ADDICTION

A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation

(2012) Antonio Waldo Zuardi et al.   CURRENT PHARMACEUTICAL DESIGN

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors

(2012) Wei Xiong et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug

(2012) Alexandre Rafael de Mello Schier et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

A web-based survey on mephedrone

(2011) R.L. Carhart-Harris et al.   DRUG AND ALCOHOL DEPENDENCE

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

(2010) Charles S. Grob et al.   ARCHIVES OF GENERAL PSYCHIATRY

Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy

(2010) Mohanraj Rajesh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis

(2010) Celia JA Morgan et al.   NEUROPSYCHOPHARMACOLOGY

Cannabidiol: A Promising Drug for Neurodegenerative Disorders?

(2009) Teresa Iuvone et al.   CNS Neuroscience & Therapeutics

Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity

(2008) M Zack et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Comparison of racemic ketamine andS-ketamine in treatment-resistant major depression: Report of two cases

(2008) Robert Paul et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY